Carillon Tower Advisers Inc. trimmed its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 4.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 64,900 shares of the healthcare conglomerate’s stock after selling 3,000 shares during the period. Carillon Tower Advisers Inc.’s holdings in UnitedHealth Group were worth $14,104,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Eastern Bank lifted its stake in UnitedHealth Group by 2.0% in the 2nd quarter. Eastern Bank now owns 69,088 shares of the healthcare conglomerate’s stock worth $16,858,000 after acquiring an additional 1,375 shares in the last quarter. Capital Investment Advisors LLC raised its stake in shares of UnitedHealth Group by 26.2% during the 2nd quarter. Capital Investment Advisors LLC now owns 6,379 shares of the healthcare conglomerate’s stock worth $1,556,000 after purchasing an additional 1,323 shares in the last quarter. Berkeley Capital Partners LLC raised its stake in shares of UnitedHealth Group by 7.4% during the 2nd quarter. Berkeley Capital Partners LLC now owns 2,220 shares of the healthcare conglomerate’s stock worth $542,000 after purchasing an additional 153 shares in the last quarter. Calton & Associates Inc. raised its stake in shares of UnitedHealth Group by 22.7% during the 2nd quarter. Calton & Associates Inc. now owns 2,074 shares of the healthcare conglomerate’s stock worth $506,000 after purchasing an additional 384 shares in the last quarter. Finally, Granite Investment Partners LLC raised its stake in shares of UnitedHealth Group by 1.8% during the 2nd quarter. Granite Investment Partners LLC now owns 67,540 shares of the healthcare conglomerate’s stock worth $16,480,000 after purchasing an additional 1,193 shares in the last quarter. 85.50% of the stock is owned by institutional investors and hedge funds.
UNH traded up $2.42 during midday trading on Wednesday, reaching $279.32. The company’s stock had a trading volume of 2,677,711 shares, compared to its average volume of 4,470,949. The stock has a market cap of $264.70 billion, a P/E ratio of 21.69, a PEG ratio of 1.48 and a beta of 0.64. The company has a fifty day simple moving average of $260.30 and a 200 day simple moving average of $245.75. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.67. UnitedHealth Group Inc has a twelve month low of $208.07 and a twelve month high of $283.00.
UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $3.88 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $3.75 by $0.13. The firm had revenue of $60.35 billion for the quarter, compared to analyst estimates of $59.84 billion. UnitedHealth Group had a return on equity of 25.30% and a net margin of 5.57%. The company’s revenue was up 6.7% on a year-over-year basis. During the same quarter last year, the firm posted $3.41 EPS. Sell-side analysts expect that UnitedHealth Group Inc will post 14.96 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be issued a $1.08 dividend. This represents a $4.32 dividend on an annualized basis and a yield of 1.55%. The ex-dividend date is Friday, December 6th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 33.54%.
In other UnitedHealth Group news, EVP D Ellen Wilson sold 7,400 shares of the firm’s stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $272.77, for a total value of $2,018,498.00. Also, CAO Thomas E. Roos sold 1,177 shares of the firm’s stock in a transaction that occurred on Thursday, November 7th. The stock was sold at an average price of $255.04, for a total value of $300,182.08. Following the completion of the sale, the chief accounting officer now owns 21,687 shares of the company’s stock, valued at approximately $5,531,052.48. The disclosure for this sale can be found here. Insiders sold a total of 38,577 shares of company stock worth $9,398,080 in the last ninety days. Insiders own 0.82% of the company’s stock.
A number of equities research analysts have recently weighed in on UNH shares. Wells Fargo & Co raised their price target on UnitedHealth Group from $288.00 to $318.00 and gave the stock an “in-line” rating in a research note on Wednesday. Morgan Stanley reaffirmed a “buy” rating and set a $312.00 price target (up from $294.00) on shares of UnitedHealth Group in a research note on Friday, November 22nd. Credit Suisse Group reissued an “outperform” rating and set a $320.00 price objective (up previously from $293.00) on shares of UnitedHealth Group in a report on Wednesday. SunTrust Banks reissued a “buy” rating and set a $335.00 price objective (up previously from $310.00) on shares of UnitedHealth Group in a report on Monday, November 18th. Finally, Deutsche Bank assumed coverage on UnitedHealth Group in a report on Thursday, September 12th. They set a “hold” rating and a $263.00 price objective on the stock. Six equities research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $298.35.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Article: Blockchain
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.